# AZD8055 for Adults With Recurrent Gliomas

> **NCT01316809** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 22 (actual)

## Conditions studied

- Glioblastoma Multiforme
- Anaplastic Astrocytoma
- Anaplastic Oligodendroglioma
- Malignant Glioma
- Brainstem Glioma

## Interventions

- **DRUG:** AZD8055

## Key facts

- **NCT ID:** NCT01316809
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03-04
- **Primary completion:** 2014-04-14
- **Final completion:** 2016-04-04
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2019-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01316809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01316809, "AZD8055 for Adults With Recurrent Gliomas". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01316809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*